BioCentury
ARTICLE | Politics, Policy & Law

A Billion Reasons

October 5, 2009 7:00 AM UTC

A billion reasons

Horse trading in the Senate Finance Committee last week could give small biotechs, molecular diagnostics companies, and independent clinical labs substantial short-term incentives to support healthcare reform legislation. Everything is subject to change, however, as the bill passes through the legislative meat grinder...